How the Month-End Close Works

The month-end close is the routine a company runs after each month ends to make its books final: record every transaction, reconcile every account, book the costs you owe but have not been billed for, explain what moved, then lock the month. A small company with clean systems can do it in 3 to 5 business days.

Everything a founder wants from finance sits on top of that routine. The board deck, the runway math, the investor update and the diligence folder are all built from closed months, so when the close is late or loose, every one of them inherits the problem. That holds for an AI startup, a biotech waiting on trial data, a pharma company heading into a raise and a specialty pharmacy living on reimbursement timing. Plenty of companies are slower than that: APQC puts the median close at 8.0 days across 3,389 organizations.¹

What does the month-end close actually include?

A month-end close is the set of accounting steps that turns a month of raw activity into financial statements you can rely on, run on a fixed schedule so every month is finished the same way. APQC's benchmark definition is plainer: "an accounting procedure undertaken at the end of the month to close out the current posting period."¹ Every company does the same five kinds of work, whether it has three transactions a day or three thousand.

Cutoff puts everything that happened in the month into the month, and keeps next month out. Reconciliation ties every cash account to its statement, and what customers owe you and what you owe vendors back to the ledger. Accruals and deferrals book costs you incurred but have not been invoiced for, spread prepaid expenses over the months they cover, and count only the revenue you earned. Review explains anything that moved against last month and budget. Reporting and lock produces the statements and closes the period.

Accruals are what make it accrual accounting, and the IRS puts the rule in one line: under an accrual method, "you generally report income in the year it is earned and deduct or capitalize expenses in the year incurred."² Swap the year for a month and you have the job of the close. NetSuite calls the same idea the matching principle, with costs landing in the period of the revenue they help produce.³

Two of my own rules keep a close honest. First, set a threshold so the close does not drown in pennies: I only set up a prepaid schedule for items of about $2,500 or more, and smaller purchases get expensed. Second, support every entry. If a number cannot be walked back to a document, a schedule or an email that explains it, it is a guess, and guesses are the first thing an auditor or a diligence team finds.

What does a 5-day close look like, day by day?

Here is the calendar I run for a small company with clean systems. The transactional steps follow a written procedure, and the review is where the judgment lives.

1. Day 1, cutoff and cash. Record the last transactions of the month, then reconcile every bank, credit card and payment processor account to its statement, to the dollar.
2. Day 2, subledgers and accruals. Close what customers owe you and what you owe vendors, book accruals for work done but not yet billed (contractors, research vendors, cloud and compute), amortize prepaids and recognize the deferred revenue you earned.
3. Day 3, tie out the balance sheet. Keep a roll forward schedule for every balance sheet account (payroll liabilities, fixed assets and depreciation, loans, equity) and tie each one to the ledger.
4. Day 4, explain what moved. Compare the month to last month and to budget, and write one line on the driver of every material change.
5. Day 5, package and lock. Produce the balance sheet, income statement and cash flow statement, a short written summary and the KPIs your board tracks, then lock the period so nothing posts into it without a review.

Day 4 is the one most small companies skip, and the one a board cares about most. A flux review (the month over month comparison) is only as good as its explanations, and Nicoletta Zucaro at Numeric puts it well: "The value is in the commentary, not the variance calculation. A number without a driver is unfinished work."⁴ When I review a close, I keep asking for the why behind the number. If you cannot tell your board why a number changed, they start to wonder which of your other numbers they can trust.

AI is starting to show up in close times. FloQast's 2026 research (sample size not published) found the most AI-mature accounting teams close in 6.7 days against 8.7 for the least mature,⁵ and Gartner predicts a 30% faster close by 2028 for finance teams using cloud ERP with embedded AI assistants.⁶ In my practice, Claude drafts the monthly commentary from the closed financials, and I validate and review every number before it reaches a client. The machine saves the hours, and the sign-off stays a person's job.

How long should the month-end close take?

For a small company with clean books, 3 to 5 business days, which is faster than most companies manage. The benchmarks disagree because they measure different companies in different ways, so here they are side by side.

My guidance to a startup is 3 to 5 business days once the books are clean, and no more than 10 while you are still cleaning up. Hitting the same day every month matters more than the number itself. A finance director in Ledge's survey put it well: "Five days gives you just enough time to be accurate without slowing down the business."⁷

Speed is not the only measure. A fast close that is wrong gets reopened after the board has already seen it. Trullion's close checklist makes the same point: "A close that was executed consistently and documented thoroughly is far easier to defend than one that was fast but undocumented."¹¹ So pick a target you can hit with the support attached, then tighten it one day at a time.

Why do accruals decide whether your close means anything?

Because the accruals are where a month either tells the truth or does not. Here is a worked example with illustrative numbers (not a client). It is March. A customer prepays $24,000 for a year of your software on March 1. A research vendor does $40,000 of work for you in March but will not invoice until May. And your cloud and compute usage for March runs about $9,000, but the bill is not final until April.

On the books, the prepay goes in as cash with a matching liability: debit cash $24,000, credit deferred revenue $24,000. Each month you earn a twelfth of it, so you debit deferred revenue $2,000 and credit revenue $2,000. The research work is accrued in the month it happened: debit research and development expense $40,000, credit accrued liabilities $40,000, reversed when the invoice arrives in May. The compute gets an estimate from your usage console: debit cost of revenue $9,000, credit accrued liabilities $9,000, trued up when the bill lands. AWS's documentation says the monthly summary "isn't an invoice until the month's activity closes and AWS calculates the final charges."¹²

Now compare the two versions of March. On a cash basis, March shows $24,000 coming in and none of those costs, so it looks like a great month. On an accrual basis, March shows $2,000 of revenue against $49,000 of costs, a $47,000 loss. Same company, same month, a $71,000 swing, and only the second version is the one an investor, a lender or a buyer will accept. It is also the only version that shows the $49,000 you already owe, which your runway has to cover even though the cash has not left yet.

Revenue follows the same logic. Under ASC 606, the core principle is that "an entity recognizes revenue to depict the transfer of promised goods or services to customers."¹³ Collecting cash first does not make it revenue, and a prepay sitting in deferred revenue is a promise you still owe. Our guide to deferred revenue in SaaS goes deeper on how that plays out in software.

Accrual work gets heavy fast as a company scales. I worked closely with a pharmaceutical client as an outside contractor on its accounting team, providing accrual accounting and supporting the monthly close as the company scaled toward a public IPO. The accrual workpapers alone ran 40 hours or more in the first week of every month.

What happens when a company skips the close?

I have lived the expensive version of this. Years ago a specialty pharmacy hired me after a private equity buyer laughed it out of the room, because its books were a mess. My first job was to go 3 years backwards and close the books under GAAP so an audit could be done. It took about 9 months. I led the move from QuickBooks to Microsoft Dynamics along the way, we got a clean audit, and the company grew from about $50 million to about $500 million in revenue before it sold to private equity.

The public version looks like Bird Global. In November 2022 the scooter company told the SEC that its prior financial statements should no longer be relied upon, because for certain customers with insufficient preloaded wallet balances, "the Company's business systems recorded revenue for uncollected balances following the completion of certain Rides that should not have been recorded."¹⁴ Bird's own release put the adjustment at $12.7 million for the first nine months of 2022,¹⁵ and the revisions totaled $31.6 million from 2020 to 2022.¹⁶ According to a securities law firm's summary, the stock fell more than 15% the day the news came out.¹⁷ A monthly tie-out of recorded revenue to cash collected is built to catch that kind of gap.

Most companies never make the news; they just reopen the books. In a Dimensional Research survey of 259 accounting and finance professionals for FloQast, released in 2017, 3 in 4 had reopened their books after the close to fix errors. Diane Hagglund, senior research analyst at Dimensional Research, summed it up: "The survey results paint a bleak picture where almost two-thirds of accounting professionals report increased stress levels during the close."¹⁸ A reopened month is a draft with a deadline attached, and often the board has already seen the draft.

What do investors, lenders and buyers expect from your close?

Financial statements on a deadline, commonly 30 to 45 days after the period ends, and after a priced round or a venture loan that deadline is often in the documents you signed. The NVCA model documents, which serve as "the industry-embraced model documents to be used in venture capital financings,"¹⁹ give investors information rights, and law firm guidance on those agreements says quarterly financial statements are typically delivered within 45 days.²⁰ Monthly reporting is a negotiation, as Morrison Foerster's startup guidance notes: "Sometimes, investors will negotiate for the right to receive monthly income statements and balance sheets."²¹ It adds that early-stage deals commonly leave that requirement out to spare a small team.

Later rounds and loans are where it shows up. An investors' rights agreement filed with Bill.com's IPO registration required monthly unaudited financial statements for major investors "within thirty (30) days after the end of each calendar month."²² Silicon Valley Bank's loan agreement with SimilarWeb required a monthly balance sheet and income statement "as soon as available, but no later than thirty (30) days after the last day of each month."²³ Once a company is public, the SEC gives it "40 days after the end of the fiscal quarter for large accelerated filers and accelerated filers" to file its 10-Q, and 45 days for everyone else.²⁴ A close that takes 20 business days, about four calendar weeks, eats most of any of those windows.

Buyers go further. A quality of earnings team rebuilds your numbers from source documents and notices fast when support is missing. Gary Stoker, then CFO and treasurer of Roth Corp., a Denver appliance distributor, told the Journal of Accountancy in 2018, "The sooner we get the books closed, the sooner we'll be able to do everything else."²⁵ For a founder, everything else is the board meeting, the raise and the sale. We do no audit or attest work at Island Waters, but a buttoned up close with a roll forward behind every balance sheet account keeps all three moving.

If you run a biotech, pharma, pharmacy or AI company, what changes?

The routine is the same; the hard accrual is different. In biotech and pharma it is clinical trial and research cost, because contract research organizations and trial sites bill in arrears while the work happens every day. Under PCAOB AS 3101, a critical audit matter is one that "involved especially challenging, subjective, or complex auditor judgment,"²⁶ and Ernst & Young named accrued clinical trial expenses as one in its report on Armata Pharmaceuticals' 2025 financial statements, citing "a high volume of data from third-party service providers and internal clinical personnel, which is tracked in spreadsheets."²⁷ There is more on our healthcare and biotech and pharma work on the site.

In a pharmacy, the hard part is reimbursement. What a PBM finally pays often differs from what the claim showed at the counter, so the close has to reconcile remittances to claims every month. In June 2023, CMS reminded Medicare Part D plan sponsors that its 2022 final rule takes effect January 1, 2024 and "requires the application of all pharmacy price concessions at the point of sale."²⁸ That changed the timing of the cash, not the need to reconcile it. I spent over a decade in the accounting seat at two specialty pharmacies, and the close that holds up there reconciles every payer, every month. Our PBM reconciliation guide shows how underpayments get found.

In AI and SaaS, the hard parts are usage and timing. Compute bills close after the month does, so they need an estimate like the one above, and subscription or usage revenue has to follow what you delivered, not what you collected. Get either one wrong and both your gross margin and your operating loss are off, and those are two of the first numbers an AI investor asks about.